BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21722267)

  • 1. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration.
    Lee MW; Kim DS; Lee JH; Lee BS; Lee SH; Jung HL; Sung KW; Kim HT; Yoo KH; Koo HH
    Cancer Sci; 2011 Oct; 102(10):1822-8. PubMed ID: 21722267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
    Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R
    Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatin.
    Lee MW; Kim DS; Min NY; Kim HT
    Int J Cancer; 2008 May; 122(10):2380-4. PubMed ID: 18224693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.
    Grabinski N; Bartkowiak K; Grupp K; Brandt B; Pantel K; Jücker M
    Cell Signal; 2011 Dec; 23(12):1952-60. PubMed ID: 21777670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.
    Cariaga-Martinez AE; López-Ruiz P; Nombela-Blanco MP; Motiño O; González-Corpas A; Rodriguez-Ubreva J; Lobo MV; Cortés MA; Colás B
    Cell Signal; 2013 Jul; 25(7):1586-97. PubMed ID: 23567263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells.
    Girouard J; Lafleur MJ; Parent S; Leblanc V; Asselin E
    Gynecol Oncol; 2013 Feb; 128(2):335-43. PubMed ID: 23174537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
    Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
    Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signaling pathways.
    Pal HC; Sharma S; Strickland LR; Agarwal J; Athar M; Elmets CA; Afaq F
    PLoS One; 2013; 8(10):e77270. PubMed ID: 24124611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells.
    Hövelmann S; Beckers TL; Schmidt M
    Br J Cancer; 2004 Jun; 90(12):2370-7. PubMed ID: 15150572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X; Jiang J; Yao L; Ji B
    Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.
    Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W
    J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth.
    Fu L; Chen W; Guo W; Wang J; Tian Y; Shi D; Zhang X; Qiu H; Xiao X; Kang T; Huang W; Wang S; Deng W
    PLoS One; 2013; 8(7):e69240. PubMed ID: 23869238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines.
    Yang Y; Ikezoe T; Nishioka C; Bandobashi K; Takeuchi T; Adachi Y; Kobayashi M; Takeuchi S; Koeffler HP; Taguchi H
    Br J Cancer; 2006 Dec; 95(12):1653-62. PubMed ID: 17133272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxin 3 acts as a functional effector of Akt/NF-κB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer.
    Li Y; Song X; Niu J; Ren M; Tang G; Sun Z; Kong F
    Arch Biochem Biophys; 2021 Apr; 701():108818. PubMed ID: 33617838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib, but not cisplatin, induces mitochondria-dependent apoptosis accompanied by up-regulation of noxa in the non-small cell lung cancer cell line NCI-H460.
    Voortman J; Checinska A; Giaccone G; Rodriguez JA; Kruyt FA
    Mol Cancer Ther; 2007 Mar; 6(3):1046-53. PubMed ID: 17363497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STIP overexpression confers oncogenic potential to human non-small cell lung cancer cells by regulating cell cycle and apoptosis.
    Tang Y; Yan G; Song X; Wu K; Li Z; Yang C; Deng T; Sun Y; Hu X; Yang C; Bai H; Li H; Tan W; Ye M; Liu J
    J Cell Mol Med; 2015 Dec; 19(12):2806-17. PubMed ID: 26354852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer.
    Virtakoivu R; Pellinen T; Rantala JK; Perälä M; Ivaska J
    Mol Biol Cell; 2012 Sep; 23(17):3357-69. PubMed ID: 22809628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin.
    Dukaew N; Chairatvit K; Pitchakarn P; Imsumran A; Karinchai J; Tuntiwechapikul W; Wongnoppavich A
    Oncol Rep; 2020 Oct; 44(4):1441-1454. PubMed ID: 32945500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
    Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.